Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ORAL7 Mouthwash is an enzyme-containing, moisturizing oral rinse designed to mimic the natural protective systems of human saliva. Developed by MBD Marketing SDN. BHD., it contains a combination of naturally derived enzymes, including glucose oxidase, lactoperoxidase, and lysozyme, along with the protein lactoferrin. These components provide antimicrobial protection against bacteria, viruses, and fungi while maintaining a neutral pH (pH7) in the oral cavity. The formulation is alcohol-free, menthol-free, and free of sodium lauryl sulphate (SLS), making it suitable for sensitive oral tissues. It is primarily used for the relief of xerostomia (dry mouth) symptoms and has been investigated in clinical trials for its ability to promote wound healing, reduce pain, and improve mouth opening following the surgical removal of impacted mandibular third molars.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ORAL7 Mouthwash.